Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

NAS report, National Academies of Sciences Engineering and Medicine, Mo-99 production, highly enriched uranium, HEU, SNMMI
News | Radiopharmaceuticals and Tracers | October 28, 2016

October 28, 2016 — The National Academies of Sciences, Engineering, and Medicine (NAS) have released a report on the...

Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016

October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3...

Siemens Healthineers, Symbia Intevo SPECT/CT system, xSPECT Quant, RSNA 2016
Technology | SPECT-CT | October 18, 2016

October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens...

Lantheus, flurpiridaz F-18, myocardial perfusion imaging, MPI, cardiac stress testing, ASNC 2016
News | Radiopharmaceuticals and Tracers | October 17, 2016

October 17, 2016 — Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3...

Philips, RSNA 2016, IQon spectral CT

IQon Spectral CT image courtesy of Philips Healthcare

News | Information Technology | October 13, 2016

October 13, 2016 — Philips announced that it will be displaying a variety of solutions aimed at increasing...

University of Arizona, Cubresa, NuPET, PET/MRI scanner installed, tumor assessment

Panel A shows a flank A549 lung tumor in a nude mouse with combined 18F-FDG PET uptake (signal intensity in color) and T2-weighted anatomical MRI (grayscale). Panel B shows a similar tumor image with a relative permeability map for the tumor (color code) overlaid on a corresponding anatomical MRI reference. Regions identified as necrotic were not included in the DCE MRI analysis. Image courtesy of the University of Arizona Department of Medical Imaging.

News | PET-MRI | October 13, 2016

October 13, 2016 — Cubresa Inc. recently announced the successful installation of their compact positron emission...

radiology

Image courtesy of Pixabay

Blog | Radiology Imaging | October 12, 2016

We know where imaging has been.

We think it’s going to...

Medic Vision, SafeCT-29, RSNA 2016, SafeCT Enterprise, SafeCT Dose Reporting
Technology | Computed Tomography (CT) | October 06, 2016

October 6, 2016 — Medic Vision is exhibiting at the 2016 Annual Meeting of the Radiological Society of North America...

Blackford Analysis, Smart Localizer, radiologic imaging comparison software, PACS, SIIM, RSNA 2016
Technology | Advanced Visualization | October 05, 2016

October 5, 2016 — Blackford Analysis officially launched its Smart Localizer product at the Society for Imaging...

silos

Image courtesy of Pixabay

Blog | Radiology Imaging | October 05, 2016

Ever knock down a silo? You have to be quick. And lucky. Very...

GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016
Technology | PET-CT | October 05, 2016

October 5, 2016 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery...

PET imaging
Feature | Radiation Oncology | October 04, 2016 | By Michael V. Knopp, M.D., Ph.D., Chadwick L. Wright, M.D., Ph.D., Katherine Binzel, Ph.D. and Jun Zhang, Ph.D.

Precision medicine is not only a buzzword, it is a call to action to radically advance our capabilities in the era...

Celesteion PET/CT
News | PET-CT | October 03, 2016

October 1, 2016 — To advance clinical care for its customers, Toshiba’s Celesteion PET/CT system delivers a more...

PET probes, breast cancer, surface receptor changes, MGH study, Memorial Sloan Kettering

After molecularly targeted therapy with an AKT inhibitor, the receptor tyrosine kinase (RTK) HER3 increases in this particular tumor, but the RTK EGFR does not. In this example, starting HER3 inhibitor therapy in addition to AKT inhibitor therapy is likely to be beneficial, but the addition of EGFR inhibitor therapy is not likely to be beneficial for treating this tumor. Image courtesy of Massachusetts General Hospital, Boston.

News | Nuclear Imaging | September 20, 2016

September 20, 2016 — Cancer biologists know that inhibitor-mediated feedback loop changes (increased expression of a...

Alzheimer's, ADNI3 study, Alzheimer's Disease Neuroimaging Initiative, NIH grant, MRI, PET, biomarkers
Feature | Neuro Imaging | September 09, 2016

September 9, 2016 — The Alzheimer’s Disease...

PET/CT

There is a growing focus on early diagnosis and prevention. Here, PET/CT imaging is used to look inside the stress center of the brain.

Feature | Radiology Imaging | September 07, 2016 | By Kirill Shalyaev, Ph.D.

Advanced imaging and hybrid modalities, such as ...

Axumin, fluciclovine F-18 injection, first injection, Northside Hospital Atlanta
News | Radiopharmaceuticals and Tracers | September 07, 2016

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...

News | Radiopharmaceuticals and Tracers | September 06, 2016

September 6, 2016 — Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with...

ASNC, SNMMI, position statement, myocardial perfusion PET, coronary artery disease
News | PET Imaging | September 01, 2016

September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of...

iDISCO, Alzheimer’s, pathology imaging

Example of the iDISCO technique to image brain samples containing Alzheimer’s disease, which could have major impact on treatment. For more inages and videos view the article online at www.cell.com/cell-reports/fulltext/S2211-1247(16)30814-2

News | Neuro Imaging | August 30, 2016

August 30, 2016 — Rockefeller University researchers have used a recently-developed imaging technique that makes...